- Home
- GCV vs XTNT Comparison
GCV vs XTNT Comparison
Compare GCV & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- XTNT
- Stock Information
- Founded
- GCV 1988
- XTNT N/A
- Country
- GCV United States
- XTNT United States
- Employees
- GCV N/A
- XTNT N/A
- Industry
- GCV Finance/Investors Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GCV Finance
- XTNT Health Care
- Exchange
- GCV Nasdaq
- XTNT Nasdaq
- Market Cap
- GCV 75.6M
- XTNT 60.9M
- IPO Year
- GCV N/A
- XTNT N/A
- Fundamental
- Price
- GCV $3.80
- XTNT $0.49
- Analyst Decision
- GCV
- XTNT Strong Buy
- Analyst Count
- GCV 0
- XTNT 1
- Target Price
- GCV N/A
- XTNT $3.00
- AVG Volume (30 Days)
- GCV 57.9K
- XTNT 43.9K
- Earning Date
- GCV 01-01-0001
- XTNT 03-06-2025
- Dividend Yield
- GCV 13.04%
- XTNT N/A
- EPS Growth
- GCV N/A
- XTNT N/A
- EPS
- GCV N/A
- XTNT N/A
- Revenue
- GCV N/A
- XTNT $117,267,000.00
- Revenue This Year
- GCV N/A
- XTNT $15.56
- Revenue Next Year
- GCV N/A
- XTNT $22.39
- P/E Ratio
- GCV N/A
- XTNT N/A
- Revenue Growth
- GCV N/A
- XTNT 28.44
- 52 Week Low
- GCV $3.15
- XTNT $0.33
- 52 Week High
- GCV $4.58
- XTNT $1.24
- Technical
- Relative Strength Index (RSI)
- GCV 47.01
- XTNT 48.33
- Support Level
- GCV $3.72
- XTNT $0.45
- Resistance Level
- GCV $3.86
- XTNT $0.51
- Average True Range (ATR)
- GCV 0.08
- XTNT 0.05
- MACD
- GCV 0.00
- XTNT 0.00
- Stochastic Oscillator
- GCV 47.37
- XTNT 54.00
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.